Literature DB >> 35857139

Motor-neuron-disease-like phenotype associated with IgLON5 disease.

Sri Raghav Sista1, Brian Crum1, Albert Aboseif2, Michelle F Devine1, Anastasia Zekeridou1,3,4, M Bakri Hammami3, Mohammed M Rezk3, André Truffert5, Patrice H Lalive5, Amy Kunchok2, Andrew McKeon1,3,4, Divyanshu Dubey6,7,8.   

Abstract

A growing spectrum of neurological manifestations are being recognized in association with IgLON5 autoimmunity, including recent reports of motor-neuron-disease-like phenotype. Here we describe four cases of IgLON5 autoimmunity with motor neuron involvement and evaluate an additional 109 probable or definite amyotrophic lateral sclerosis cases seen in our neuromuscular clinic for IgLON5-IgG seropositivity. The presence of parasomnias, vocal cord dysfunction or hyperkinetic movements in a patient with motor-neuron-disease-like phenotype should prompt evaluation for IgLON5-IgG autoantibodies. Recognition and treatment of this autoimmune disease with immunosuppressive agents may bring about significant neurological improvement in a minority of cases.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; IgLON5 autoimmunity; Motor neuron disease

Mesh:

Substances:

Year:  2022        PMID: 35857139      PMCID: PMC9578379          DOI: 10.1007/s00415-022-11262-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  11 in total

1.  Motor neuron disease-like phenotype associated with anti-IgLON5 disease.

Authors:  Qing-Qing Tao; Qiao Wei; Shui-Jiang Song; Xin-Zhen Yin
Journal:  CNS Neurosci Ther       Date:  2018-08-13       Impact factor: 5.243

2.  Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration.

Authors:  Jon Landa; Carles Gaig; Jesús Plagumà; Albert Saiz; Ana Antonell; Raquel Sanchez-Valle; Josep Dalmau; Francesc Graus; Lidia Sabater
Journal:  Ann Neurol       Date:  2020-08-27       Impact factor: 10.422

3.  Expanding the Clinical Spectrum of IgLON5-Syndrome.

Authors:  Stephan Wenninger
Journal:  J Neuromuscul Dis       Date:  2017

Review 4.  Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease.

Authors:  Carles Gaig; Yaroslau Compta
Journal:  Curr Opin Neurol       Date:  2019-06       Impact factor: 5.710

5.  Case 1-2022: A 67-Year-Old Man with Motor Neuron Disease and Odd Behaviors during Sleep.

Authors:  Aleksandar Videnovic; Suma Babu; Brian Zhao; Haatem M Reda; Jenny J Linnoila
Journal:  N Engl J Med       Date:  2022-01-13       Impact factor: 91.245

6.  A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.

Authors:  Lidia Sabater; Carles Gaig; Ellen Gelpi; Luis Bataller; Jan Lewerenz; Estefanía Torres-Vega; Angeles Contreras; Bruno Giometto; Yaroslau Compta; Cristina Embid; Isabel Vilaseca; Alex Iranzo; Joan Santamaría; Josep Dalmau; Francesc Graus
Journal:  Lancet Neurol       Date:  2014-04-03       Impact factor: 44.182

7.  Neuropathological criteria of anti-IgLON5-related tauopathy.

Authors:  Ellen Gelpi; Romana Höftberger; Francesc Graus; Helen Ling; Janice L Holton; Timothy Dawson; Mara Popovic; Janja Pretnar-Oblak; Birgit Högl; Erich Schmutzhard; Werner Poewe; Gerda Ricken; Joan Santamaria; Josep Dalmau; Herbert Budka; Tamas Revesz; Gabor G Kovacs
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

8.  IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.

Authors:  Josephe A Honorat; Lars Komorowski; Keith A Josephs; Kai Fechner; Erik K St Louis; Shannon R Hinson; Sabine Lederer; Neeraj Kumar; Avi Gadoth; Vanda A Lennon; Sean J Pittock; Andrew McKeon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-07-18

9.  Understanding anti-IgLON5 disease.

Authors:  Francesc Graus; Joan Santamaría
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-08-24

10.  Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy.

Authors:  Maria Elena Erro; Lidia Sabater; Laura Martínez; María Herrera; Aiora Ostolaza; Iñaki García de Gurtubay; Teresa Tuñón; Francesc Graus; Ellen Gelpi
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.